C10H12N2O5 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-on, 2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)- 7-Methyl-, (2R,3R,3aS,9aR)- (9CI, ACI)

Kanonesch SMILES

O=C1N=C2OC3C(O)C(OC3N2C=C1C)CO

Isomeric SMILES

O[C@H]1[C@]2([C@](N3C(O2)= NC(=O)C(C)=C3)(O[C@@H]1CO)[H])[ H]

InChI

InChI= 1S/C10H12N2O5/c1-4-2-12-9-7(6(14)5(3-13)16-9)17-10(12)11-8(4)15/h2,5- 7,9,13-14H,3H2,1H3/t5-,6-,7+,9-/m1/s1

InChI Schlëssel

WLLOAUCNUMYOQI-JAGXHNFQSA-N

17 Aner Nimm fir dës Substanz

(2R,3 R,3a anS,9a anR)-2,3,3a,9a-Tetrahydro-3-Hydroxy-2-(Hydroxymethyl)-7-methyl-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-on (ACI);

6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-on, 2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-7-methyl- (6Cl, 7Cl, 8Cl); 6H- Fuer

[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-on, 2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-7-methyl-, [2R-(2α,3β,3aβ,9aβ)]- (ZCI);

11: PN: US20040014699 PAGE: 18 behaapt DNA; 12: PN: US20040005565 PAGE: 17- 22 behaapt DNA; 12: PN: US20040005570 PAGE: 18 behaapt DNA; 12: PN: US20040006029 PAGE: 21 behaapt DNA; 12: PN: US20040014051 PAGE: 21 behaapt DNA; 1: PN: WO20050 06958 PAGE: 59 behaapt DNA; 2,2'-Anhydro(1-β-D-arabinofuranosyl)-5-methyluracil; 3: PN: WO2005007825 SÄIT: 59 behaapt DNA; 84: PN: US20040005707 SÄIT: 18 behaapt DNA; 9: PN: US20040014048 SIDE: 19 behaapt DNA; 9: PN: US20040014049 PAGE: 19

behaapt DNA;O2,2'-Anhydro-5-methyluridin; O2,2'-Anhydro-5-methyluridin; TK 112690